TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE
6.1. Overview
6.2. Wearable
6.3. Mobile Based Applications
6.4. Sensors
6.5. Others
7. GLOBAL DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE
7.1. Overview
7.2. Diagnostic Digital Biomarkers
7.3. Monitoring Digital Biomarkers
7.4. Predictive and Prognostic Digital Biomarkers
7.5. Others
8. GLOBAL DIGITAL BIOMARKERS MARKET, BY END USE
8.1. Overview
8.2. Healthcare Companies
8.3. Healthcare Providers
8.4. Payers
8.5. Others
9. GLOBAL DIGITAL BIOMARKERS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global DIGITAL BIOMARKERS Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global DIGITAL BIOMARKERS Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. ActiGraph LLC
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. AliveCor Inc
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Koneksa
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Altido Inc
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Amgen Inc
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Biogen Inc
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Empatica Inc
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Vivi Sense
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. IXICO plc
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Adherium Limited
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Neurotrack Technologies Inc
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Aural Analytic
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Huma
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Sonde Health Inc
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL DIGITAL BIOMARKERS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL DIGITAL BIOMARKERS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 9 US: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 11 US: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 12 CANADA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 14 CANADA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 10 ITALY: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 ITALY: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 12 ITALY: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 16 UK: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 17 UK: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 18 UK: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 28 CHINA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 CHINA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 30 CHINA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 31 INDIA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 INDIA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 33 INDIA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: DIGITAL BIOMARKERS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: DIGITAL BIOMARKERS MARKET, BY CLINICAL PRACTICE, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: DIGITAL BIOMARKERS MARKET, BY END USE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DIGITAL BIOMARKERS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DIGITAL BIOMARKERS MARKET
FIGURE 4 GLOBAL DIGITAL BIOMARKERS MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL DIGITAL BIOMARKERS MARKET, SHARE (%), BY CLINICAL PRACTICE, 2022
FIGURE 6 GLOBAL DIGITAL BIOMARKERS MARKET, SHARE (%), BY END USE, 2022
FIGURE 7 GLOBAL DIGITAL BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: DIGITAL BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: DIGITAL BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: DIGITAL BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: DIGITAL BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL DIGITAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 ACTIGRAPH LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ACTIGRAPH LLC: SWOT ANALYSIS
FIGURE 15 ALIVECOR INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 ALIVECOR INC: SWOT ANALYSIS
FIGURE 17 ALTIDO INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 ALTIDO INC: SWOT ANALYSIS
FIGURE 19 AMGEN INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 AMGEN INC: SWOT ANALYSIS
FIGURE 21 BIOGEN INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BIOGEN INC: SWOT ANALYSIS
FIGURE 23 EMPATICA INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 EMPATICA INC: SWOT ANALYSIS
FIGURE 25 VIVO SENSE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 VIVO SENSE: SWOT ANALYSIS
FIGURE 27 IXICO PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 IXICO PLC: SWOT ANALYSIS
FIGURE 29 ADHERIUM LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 ADHERIUM LIMITED: SWOT ANALYSIS
FIGURE 31 NEUROTRACK TECHNOLOGIES INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 NEUROTRACK TECHNOLOGIES INC: SWOT ANALYSIS
FIGURE 33 AURAL ANALYTIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 AURAL ANALYTIC: SWOT ANALYSIS
FIGURE 35 HUMA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 HUMA: SWOT ANALYSIS
FIGURE 37 SONDE HEALTH INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 SONDE HEALTH INC: SWOT ANALYSIS
